Correlation Between Gilead Sciences and Dr Reddys

Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gilead Sciences and Dr Reddys Laboratories, you can compare the effects of market volatilities on Gilead Sciences and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Dr Reddys.

Diversification Opportunities for Gilead Sciences and Dr Reddys

-0.75

Correlation Coefficient

Gilead Sciences  Dr Reddys

Pay attention - limited upside

The 3 months correlation between Gilead and RDY is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Dr Reddys go up and down completely randomly.

Pair Corralation between Gilead Sciences and Dr Reddys

Given the investment horizon of 90 days Gilead Sciences is expected to generate 4.75 times less return on investment than Dr Reddys. In addition to that, Gilead Sciences is 1.36 times more volatile than Dr Reddys Laboratories. It trades about 0.01 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.07 per unit of volatility. If you would invest  1,424  in Dr Reddys Laboratories on September 15, 2024 and sell it today you would earn a total of  22.00  from holding Dr Reddys Laboratories or generate 1.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Gilead Sciences  vs.  Dr Reddys Laboratories

Gilead Sciences

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent essential indicators, Gilead Sciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Gilead Sciences and Dr Reddys

The main advantage of trading using opposite Gilead Sciences and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.

The idea behind Gilead Sciences and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.